BPG is committed to discovery and dissemination of knowledge
Articles Published Processes
7/31/2024 2:48:45 AM | Browse: 125 | Download: 687
 |
Received |
|
2024-02-05 18:32 |
 |
Peer-Review Started |
|
2024-02-05 18:32 |
 |
First Decision by Editorial Office Director |
|
2024-05-18 17:10 |
 |
Return for Revision |
|
2024-05-18 17:10 |
 |
Revised |
|
2024-05-18 18:28 |
 |
Publication Fee Transferred |
|
|
 |
Second Decision by Editor |
|
2024-06-14 02:45 |
 |
Second Decision by Editor-in-Chief |
|
|
 |
Final Decision by Editorial Office Director |
|
2024-06-14 08:37 |
 |
Articles in Press |
|
2024-06-14 08:37 |
 |
Edit the Manuscript by Language Editor |
|
2024-06-19 21:29 |
 |
Typeset the Manuscript |
|
2024-07-31 02:48 |
 |
Publish the Manuscript Online |
|
2024-07-31 02:48 |
| ISSN |
2307-8960 (online) |
| Open Access |
This article is an open-access article that was selected by an in-house editor and fully peer-reviewed by external reviewers. It is distributed in accordance with the Creative Commons Attribution NonCommercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited and the use is non-commercial. See: http://creativecommons.org/licenses/by-nc/4.0/ |
| Copyright |
©The Author(s) 2024. Published by Baishideng Publishing Group Inc. All rights reserved. |
| Article Reprints |
For details, please visit: http://www.wjgnet.com/bpg/gerinfo/247
|
| Permissions |
For details, please visit: http://www.wjgnet.com/bpg/gerinfo/207
|
| Publisher |
Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA |
| Website |
http://www.wjgnet.com |
| Category |
Neurosciences |
| Manuscript Type |
Editorial |
| Article Title |
Predictors of prognosis in Alzheimer’s disease: The role of cognitive dysfunction, immune abnormalities, and advanced neuroimaging
|
| Manuscript Source |
Invited Manuscript |
| All Author List |
Hafsa Arshad Raja and Abdulqadir J Nashwan |
| ORCID |
|
| Funding Agency and Grant Number |
|
| Corresponding Author |
Abdulqadir J Nashwan, MSc, Research Scientist, Nursing Department, Hamad Medical Corporation, Rayyan Road, Doha 3050, Qatar. anashwan@hamad.qa |
| Key Words |
Amyloid beta peptide; Alzheimer's disease; Dementia; Cellular immunity; Prognosis; T lymphocytes; Magnetic resonance spectroscopy |
| Core Tip |
Alzheimer’s disease (AD) is a serious condition leading to cognitive and social challenges. A recent study found that poor prognosis in AD patients is linked to abnormal cellular immune function, extrapyramidal symptoms, altered consciousness, abnormal electroencephalogram, increased neutrophil-lymphocyte ratio, and severe pneumonia. Impaired cellular immune function, particularly reduced T lymphocytes in the blood, is an independent predictor of poor prognosis. Early and continuous use of AD medications is associated with better outcomes. |
| Publish Date |
2024-07-31 02:48 |
| Citation |
Raja HA, Nashwan AJ. Predictors of prognosis in Alzheimer’s disease: The role of cognitive dysfunction, immune abnormalities, and advanced neuroimaging. World J Clin Cases 2024; 12(27): 6004-6006 |
| URL |
https://www.wjgnet.com/2307-8960/full/v12/i27/6004.htm |
| DOI |
https://dx.doi.org/10.12998/wjcc.v12.i27.6004 |
All content on this site: Copyright © 1993-2026 Baishideng Publishing Group Inc, its licensors, and contributors. All rights are reserved, including those for text and data mining, AI training, and similar technologies. For all open access content, the relevant licensing terms apply.